Molecular epidemiology of pancreatic cancer
- PMID: 12909734
- DOI: 10.1385/IJGC:33:1:3
Molecular epidemiology of pancreatic cancer
Abstract
Pancreatic cancer is the fourth leading cause of cancer-related death in the United States. Currently there is no early diagnostic test and no effective treatment options for this deadly disease. Prevention of pancreatic cancer is difficult because little is known about its etiology. The main modifiable risk factors for pancreatic cancer include cigarette smoking and dietary factors. Information from molecular epidemiological study of pancreatic cancer is very limited. DNA adducts derived from exposure to polycyclic aromatic hydrocarbon, aromatic amines, and heterocyclic amines have been detected in human pancreatic tissues. DNA damages derived from oxidative stress and lipid peroxidation are also present in the pancreas. No study has demonstrated a main effect of carcinogen-metabolizing genes and DNA repair genes on the risk of pancreatic cancer thus far. However, significant effects of these genes have been observed among individuals with known carcinogen exposure, such as smoking. A number of environmental and lifestyle factors, such as smoking, alcohol, coffee consumption, and exposure to organochlorine or hydrocarbon solvent, have been associated with the frequency and spectrum of K-ras mutation in pancreatic tumors. Dietary folate intake and serum levels of folate have been associated with the risk of pancreatic cancer among male smokers. These findings demonstrate the potential of the molecular epidemiology approach in understanding the etiology of pancreatic cancer. Further efforts should be made to understand the interactive relationship between genetic and environmental factors in the etiology of pancreatic cancer, which will in turn be important in identifying the high-risk population for the primary prevention of this deadly disease.
Similar articles
-
Molecular epidemiology of pancreatic cancer.Cancer J. 2001 Jul-Aug;7(4):259-65. Cancer J. 2001. PMID: 11561602 Review.
-
DNA adducts in human pancreatic tissues and their potential role in carcinogenesis.Cancer Res. 1998 Jan 1;58(1):38-41. Cancer Res. 1998. PMID: 9426054
-
K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1223-32. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11097231
-
Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.Environ Health Perspect. 1992 Nov;98:167-78. doi: 10.1289/ehp.9298167. Environ Health Perspect. 1992. PMID: 1486846 Free PMC article. Review.
-
DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.Mutat Res. 2002 Jan 15;513(1-2):37-48. doi: 10.1016/s1383-5718(01)00291-1. Mutat Res. 2002. PMID: 11719088
Cited by
-
Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies.Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):765-76. doi: 10.1158/1055-9965.EPI-08-0880. Epub 2009 Mar 3. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19258474 Free PMC article.
-
Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer.Cancer. 2007 Mar 1;109(5):840-8. doi: 10.1002/cncr.22468. Cancer. 2007. PMID: 17265526 Free PMC article.
-
A Systematic Review and Meta-Analysis: Volatile Organic Compound Analysis in the Detection of Hepatobiliary and Pancreatic Cancers.Cancers (Basel). 2023 Apr 14;15(8):2308. doi: 10.3390/cancers15082308. Cancers (Basel). 2023. PMID: 37190235 Free PMC article. Review.
-
Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview.Front Pharmacol. 2022 Aug 24;13:933457. doi: 10.3389/fphar.2022.933457. eCollection 2022. Front Pharmacol. 2022. PMID: 36091785 Free PMC article. Review.
-
The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations.Int J Gastrointest Cancer. 2006;37(4):139-45. doi: 10.1007/s12029-007-9005-8. Int J Gastrointest Cancer. 2006. PMID: 18049799
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous